Vitamins that may be helpful
People with eating disorders who restrict their food intake are at risk for multiple nutrient deficiencies, including protein, calcium, iron, riboflavin, niacin,13 folic acid,14 vitamin A, vitamin C,15 and vitamin B6,16 and essential fatty acids.17 A general multivitamin-mineral formula can reduce the detrimental health effects of these deficiencies.
In a preliminary study of women with anorexia nervosa, those
who supplemented with 45 mg of vitamin K2 per day for approximately one year
experienced significantly less bone loss, compared with women who did not take
the supplement.18 This study suggests that
supplementing with vitamin K2 may help prevent osteoporosis, which is a common
complication of anorexia nervosa. The amount of vitamin K2 used in this study
was much larger than the amount of vitamin K found in food and most supplements.
Moreover, vitamin K2 is not yet generally available as a supplement, although it
can be obtained through some nutritionally oriented doctors. Individuals
interested in using this treatment should be monitored by a doctor.
Zinc deficiency has also been detected in people with anorexia or bulimia in most,19 20 though not all,21 studies. In addition, some of the manifestations of zinc deficiency, such as reduced appetite, taste, and smell, are similar to symptoms observed in some cases of anorexia or bulimia.22
In an uncontrolled trial, supplementation with 45–90 mg per day of zinc resulted in weight gain in 17 out of 20 anorexics after 8–56 months.23 In a double-blind study, 35 women hospitalised with anorexia, given 14 mg of zinc per day, achieved a 10% increase in weight twice as fast as the group that received a placebo.24 In another report, a group of adolescent girls with anorexia, some of whom were hospitalised, was found to be consuming 7.7 mg of zinc per day in their diet—only half the recommended amount.25 Providing these girls with 50 mg of zinc per day in a double-blind trial helped diminish their depression and anxiety levels, but had no significant effect on weight gain. Anyone taking zinc supplements for more than a few weeks should also supplement with 1 to 3 mg per day of copper to prevent a zinc-induced copper deficiency.
Serotonin, a hormone that helps regulate food intake and appetite, is synthesised in the brain from the amino acid L-tryptophan. Preliminary data suggest that some people with bulimia have low serotonin levels.26 Researchers have reported that bulimic women with experimentally induced tryptophan deficiency tend to eat more and become more irritable compared to healthy women fed the same diet,27 28 though not all studies have demonstrated these effects.29
Weight-loss diets result in lower L-tryptophan and serotonin levels in women,30 which could theoretically trigger bingeing and purging in susceptible people. However, the benefits of L-tryptophan supplementation are unclear. One small, double-blind trial reported significant improvement in eating behaviour, feelings about eating, and mood among women with bulimia who were given 1 gram of L-tryptophan and 45 mg of vitamin B6 three times per day.31 Other double-blind studies using only L-tryptophan have failed to confirm these findings.32 33 L-tryptophan is available by prescription only; most drug stores do not carry it, but “compounding” pharmacies do. Most cities have at least one compounding chemist, which prepares customized prescription medications to meet individual patient’s needs.
Another serotonin precursor, 5-HTP (5-hydroxytryptophan), has been shown to reduce appetite in weight-control and diabetes trials.34 35 36 However, what effect 5-HTP has, if any, on people with binge eating disorder, bulimia, or anorexia is unknown. Unlike L-tryptophan, 5-HTP is available from health food stores and some pharmacies without prescription.
Are there any side effects or interactions?
Refer to the individual supplement for information about
any side effects or interactions.
References
1. Zerbe KJ. Anorexia nervosa and bulimia nervosa. When the pursuit of bodily
‘perfection’ becomes a killer. Postgrad Med 1996;99:161–4, 167–9
[review].
2. Garner DM, Garner MV, Rosen LW. Anorexia nervosa “restricters who purge”: implications
for subtyping anorexia nervosa. Int J Eat Disord 1993;13:171–85.
3. Spitzer RL, Yanovski
S, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat
Disord 1993;13:137–53.
4. Drewnowski A, Halmi KA, Pierce B, et al. Taste and eating disorders. Am J Clin Nutr 1987;46:442–50.
5. Casper RC, Pandy GN, Jaspan JB, Rubenstein AH. Hormone and metabolite plasma levels after oral glucose in bulimia and healthy controls. Biol Psychiatry 1988;24:663–74.
6. Drewnowski A, Halmi KA, Pierce B, et al. Taste and eating disorders. Am J Clin Nutr 1987;46:442–50.
7. van der Ster Wallin G, Norring C, Holmgren S. Binge eating versus nonpurged eating in bulimics: is there a carbohydrate craving after all? Acta Psychiatr Scand 1994;89:376–81.
8. Blouin AG, Blouin J, Bushnik T, et al. A double-blind placebo-controlled glucose challenge in bulimia nervosa: psychological effects. Biol Psychiatry 1993;33:160–8.
9. Johnson WG, Jarrell MP, Chupurdia KM, Williamson DA. Repeated binge/purge cycles in bulimia nervosa: role of glucose and insulin. Int J Eat Disord 1994;15:331–41.
10. Dalvit-McPhillips S. A dietary approach to bulimia. Physiol Behav 1984;33:769–75.
11. Davis C, Katzman DK, Kaptein S, et al. The prevalence of high-level exercise disorders: etiological implications. Compr Psychiatry 1997;38:321–6.
12. Davis C, Kennedy SH, Ravelski E, Dionne M. The role of physical activity in the development and maintenance of eating disorders. Psychol Med 1994;24:957–67.
13. Thibault L, Roberge AG. The nutritional status of subjects with anorexia nervosa. Int J Vitam Nutr Res 1987;57:447–52.
14. Abou-Saleh MT, Coppen A. The biology of folate in depression: implications for nutritional hypotheses of the psychoses. J Psychiatr Res 1986;20:91–101 [review].
15. Beaumont PJ, Chambers TL, Rouse L, Abraham SF. The diet composition and nutritional knowledge of patients with anorexia nervosa. J Hum Nutr 1981;35:265–73.
16. Rock CL, Vasantharajan S. Vitamin status of eating disorder patients: relationship to clinical indices and effect of treatment. Int J Eat Disord 1995;18:257–62.
17. Langan SM, Farrell PM. Vitamin E, vitamin A and essential fatty acid status of patients hospitalized for anorexia nervosa. Am J Clin Nutr 1985;41:1054–60.
18. Iketani T, Kiriike N, Murray, et al. Effect of
menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia
nervosa. Psychiatry Res 2003;117:259–69.
19. Humphries L, Vivian B, Stuart M, McClain CJ. Zinc deficiency and eating disorders. J Clin Psychiatry 1989;50:456–9.
20. Varela P, Marcos A, Navarro MP. Zinc status in anorexia nervosa. Ann Nutr Metab 1992;36:197–202.
21. Roijen SB, Worsaae U, Zlotnik G. Zinc in patients with anorexia nervosa. Ugeskr Laeger 1991;153:721–3 [in Danish].
22. McClain CJ, Stuart MA, Vivian B, et al. Zinc status before and after zinc supplementation of eating disorder patients. J Am Coll Nutr 1992;11:694–700.
23. Safai-Kutti S. Oral zinc supplementation in anorexia nervosa. Acta Psychiatr Scand Suppl 1990;361:14–7.
24. Birmingham CL, Goldner Em, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eat Disord 1994;15:251–5.
25. Katz RL, Keen CL, Litt IF, et al. Zinc deficiency in anorexia nervosa. J Adolesc Health Care 1987;8:400–6.
26. Kaye WH, Weltzin TE. Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood. J Clin Psychiatry 1991;52 Suppl:41–8 [review].
27. Smith KA, Fairburn CG, Cowen PJ. Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry 1999;56:171–6.
28. Weltzin TE, Fernstrom MH, Fernstrom JD, et al. Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa. Am J Psychiatry 1995;152:1668–71.
29. Oldman AD, Walsh AES, Salkovskis P, et al. Biochemical and behavioural effects of acute tryptophan depletion in abstinent bulimic subjects: a pilot study. Psychol Med 1995;25:995–1001.
30. Anderson IM, Parry-Billings M, Newsholme EA, et al. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med 1990;20:785–91.
31. Mira M, Abraham S. L-tryptophan as an adjunct to treatment of bulimia nervosa. Lancet 1989;ii:1162–3 [letter].
32. Krahn D, Mitchell J. Use of L-tryptophan in treating bulimia. Am J Psychiatry 1985;142:1130 [letter].
33. Brewerton TD, Murphy DL, Jimerson DC. Testmeal responses following m-chlorophenylpiperazine and L-tryptophan in bulimics and controls. Neuropsychopharmacology 1994;11:63–71.
34. Ceci F, Cangiano C, Cairella M, et al. The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects. J Neural Transmission 1989;76:109–17.
35. Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr 1992;56:863–7.
36. Cangiano C, Laviano A, Del Ben M, et al. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients. Int J Obes Relat Metab Disord 1998;22:648–54.
37. Peterson CB, Mitchell JE. Psychosocial and pharmacological treatment of eating disorders: a review of research findings. J Clin Psychol 1999;55:685–97 [review].
38. Mitchell JE, Raymond N, Specker S. A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa. Int J Eat Disord 1993;14:229–47 [review].
39. Thackwray DE, Smith MC, Bodfish JW, Meyers AW. A comparison of behavioral and cognitive-behavioral interventions for bulimia nervosa. J Consult Clin Psychol 1993;61:639–45.
40. Agras WS. Nonpharmacologic treatments of bulimia nervosa. J Clin Psychiatry 1991;52 Suppl:29–33 [review].
41. Fairburn CG, Norman PA, Welch SL, et al. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Arch Gen Psychiatry 1995;52:304–12.
42. Peterson CB, Mitchell JE, Engbloom S, et al. Group cognitive-behavioral treatment of binge eating disorder: a comparison of therapist-led versus self-help formats. Int J Eat Disord 1998;24:125–36.
43. Wilfley DE, Agras WS, Telch CF, et al. Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: a controlled comparison. J Consult Clin Psychol 1993;61:296–305.
44. Carter JC, Fairburn CG. Cognitive-behavioral self-help for binge eating disorder: a controlled effectiveness study. J Consult Clin Psychol 1998;66:616–23.
45. Pike KM. Long-term course of anorexia nervosa: response, relapse, remission, and recovery. Clin Psychol Rev 1998;18:447–75 [review].
46. Eisler I, Dare C, Russell GF, et al. Family and individual therapy in anorexia nervosa. A 5-year follow-up. Arch Gen Psychiatry 1997;54:1025–30.
47. Gowers S, Norton K, Halek C, Crisp AH. Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. Int J Eat Disord 1994;15:165–77.
48. Treasure J, Todd G, Brolly M, et al. A pilot study of a randomised trial of cognitive analytical therapy vs educational behavioral therapy for adult anorexia nervosa. Behav Res Ther 1995;33:363–7.
49. Robin AL, Siegel PT, Koepke T, et al. Family therapy versus individual therapy for adolescent females with anorexia nervosa. J Dev Behav Pediatr 1994;15:111–6.
50. Treasure J, Todd G, Brolly M, et al. A pilot study of a randomised trial of cognitive analytical therapy vs educational behavioral therapy for adult anorexia nervosa. Behav Res Ther 1995;33:363–7.